Total Payments
$428,195
2024 Payments
$37,561
Companies
18
Transactions
548
Medicare Patients
1,034
Medicare Billing
$756,046
Payment Breakdown by Category
Other$303,045 (70.8%)
Consulting$68,267 (15.9%)
Travel$39,102 (9.1%)
Food & Beverage$17,411 (4.1%)
Education$369.80 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $232,300 | 79 | 54.3% |
| Honoraria | $70,745 | 28 | 16.5% |
| Consulting Fee | $68,267 | 33 | 15.9% |
| Travel and Lodging | $39,102 | 109 | 9.1% |
| Food and Beverage | $17,411 | 293 | 4.1% |
| Education | $369.80 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $120,330 | 129 | $0 (2022) |
| Ipsen Biopharmaceuticals, Inc | $101,366 | 95 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $87,415 | 97 | $0 (2020) |
| ABBVIE INC. | $70,657 | 86 | $0 (2024) |
| US WorldMeds, LLC | $21,626 | 62 | $0 (2020) |
| Ipsen Innovation | $5,735 | 5 | $0 (2020) |
| Merz Pharmaceuticals, LLC | $5,605 | 33 | $0 (2024) |
| Merz Pharmaceuticals GmbH | $4,443 | 1 | $0 (2017) |
| Ipsen Biopharm Limited | $4,380 | 1 | $0 (2021) |
| Pacira Pharmaceuticals Incorporated | $2,183 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37,561 | 65 | ABBVIE INC. ($29,071) |
| 2023 | $47,457 | 68 | Ipsen Biopharmaceuticals, Inc ($24,410) |
| 2022 | $47,016 | 48 | ABBVIE INC. ($21,010) |
| 2021 | $62,466 | 47 | Allergan, Inc. ($41,457) |
| 2020 | $28,366 | 34 | Allergan, Inc. ($9,832) |
| 2019 | $76,365 | 141 | Merz North America, Inc. ($27,652) |
| 2018 | $64,008 | 70 | Merz North America, Inc. ($34,581) |
| 2017 | $64,955 | 75 | MERZ NORTH AMERICA, INC. ($22,590) |
All Payment Transactions
548 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/18/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $38.76 | General |
| Category: Musculoskeletal | ||||||
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/14/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: Musculoskeletal | ||||||
| 11/13/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Musculoskeletal | ||||||
| 11/09/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $89.22 | General |
| Category: Musculoskeletal | ||||||
| 11/09/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $46.84 | General |
| Category: Musculoskeletal | ||||||
| 11/08/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $37.21 | General |
| Category: Musculoskeletal | ||||||
| 11/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $57.68 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $42.26 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $124.12 | General |
| Category: Pain Management | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $34.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Neurology | ||||||
| 08/15/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Musculoskeletal | ||||||
| 08/15/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: Musculoskeletal | ||||||
| 07/25/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $127.52 | General |
| Category: Musculoskeletal | ||||||
| 07/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 377 | 4,218 | $1.8M | $295,485 |
| 2022 | 3 | 221 | 2,470 | $1.0M | $165,153 |
| 2021 | 4 | 212 | 2,098 | $852,000 | $145,754 |
| 2020 | 4 | 224 | 2,187 | $895,620 | $149,655 |
Total Patients
1,034
Total Services
10,973
Medicare Billing
$756,046
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 187 | 3,901 | $1.7M | $257,589 | 15.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 152 | 154 | $83,160 | $21,676 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 163 | $23,472 | $16,220 | 69.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 95 | 2,186 | $944,352 | $130,928 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 198 | $28,512 | $20,276 | 71.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 85 | 86 | $46,440 | $13,948 | 30.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 86 | 1,801 | $778,032 | $109,935 | 14.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 209 | $30,096 | $22,557 | 75.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 70 | 72 | $38,880 | $11,848 | 30.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 16 | $4,992 | $1,414 | 28.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 75 | 1,864 | $805,248 | $116,232 | 14.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 41 | 142 | $20,448 | $12,097 | 59.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 49 | 122 | $38,064 | $10,992 | 28.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 59 | 59 | $31,860 | $10,333 | 32.4% |
About Dr. Ziyad Ayyoub, M.D
Dr. Ziyad Ayyoub, M.D is a Spinal Cord Injury Medicine healthcare provider based in Paramount, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356451579.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ziyad Ayyoub, M.D has received a total of $428,195 in payments from pharmaceutical and medical device companies, with $37,561 received in 2024. These payments were reported across 548 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($232,300).
As a Medicare-enrolled provider, Ayyoub has provided services to 1,034 Medicare beneficiaries, totaling 10,973 services with total Medicare billing of $756,046. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Spinal Cord Injury Medicine
- Other Specialties Pain Medicine, General Practice
- Location Paramount, CA
- Active Since 08/30/2006
- Last Updated 04/12/2023
- Taxonomy Code 2081P0004X
- Entity Type Individual
- NPI Number 1356451579
Products in Payments
- BOTOX (Biological) $159,985
- XEOMIN (Biological) $62,301
- DYSPORT (Drug) $49,613
- Dysport (Drug) $47,570
- Xeomin (Biological) $33,132
- BOTOX (Drug) $25,335
- Dysport 300 U-1 (Drug) $16,083
- MYOBLOC (Biological) $15,053
- APOKYN (Drug) $4,439
- BOTOX NEURO REHAB (Drug) $3,472
- Xadago (Drug) $1,634
- Zilretta (Drug) $1,175
- Iovera (Device) $1,009
- MYOBLOC (Drug) $880.00
- Senza Spinal Cord Stimulation System (Device) $721.14
- DAXI (Drug) $137.99
- ELIQUIS (Drug) $125.00
- DAXXIFY (Drug) $124.85
- BOTOX - NEURO REHAB (Drug) $38.97
- BOTOX THERAPEUTIC (Biological) $30.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.